The PROTECTOR strategy employs dCas orthologs to sterically shield off-target sites from CRISPR/Cas activity
Abstract Off-target mutagenesis of CRISPR/Cas systems must be solved to facilitate safe gene therapy. Here, we report a novel approach, termed "PROTECTOR", to shield known off-target sites by directing the binding of an orthologous nuclease-dead Cas protein to the off-target site to steric...
Main Authors: | Daniel M. Sapozhnikov, Moshe Szyf |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-29332-2 |
Similar Items
-
Increasing Specificity of Targeted DNA Methylation Editing by Non-Enzymatic CRISPR/dCas9-Based Steric Hindrance
by: Daniel M. Sapozhnikov, et al.
Published: (2023-04-01) -
CRISPR/dCas9-Based Systems: Mechanisms and Applications in Plant Sciences
by: Chou Khai Soong Karlson, et al.
Published: (2021-09-01) -
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
by: Colette Moses, et al.
Published: (2019-03-01) -
Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells
by: Nasir Javaid, et al.
Published: (2021-01-01) -
Competition-based CRISPR-dCas9 transcriptional control mechanisms and application of dCas9 biosensors for high-throughput, cell-based protease inhibitor screens
by: Anderson, Daniel Allen
Published: (2022)